Exubera U.S. Regulatory Update Coming Soon, Pfizer Says

Pfizer believes it soon will be in a position to provide a regulatory update on the status of inhaled insulin. Company cites its Exubera partnership with Sanofi-Aventis and Nektar as an example of successful collaboration, although questions about the “change-of-control” provision with Sanofi-Aventis remain.